The global Erythropoietin Biosimilar market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Hospital Pharmacy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Erythropoietin Biosimilar include Pfizer, VHB Life Sciences, Chengdu Di'Ao Pharmaceutical Group, Chalver Laboratorios, Fresenius Kabi, Neiss Labs, Micro Labs, Zuventus Healthcare and RPG Life Sciences, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Erythropoietin (EPO) is the major glycoprotein hormone regulator of mammalian erythropoiesis , and is produced by kidney and liver in an oxygen-dependent manner. The biological effects of EPO are mediated by the specific erythropoietin receptor (EPOR) on bone marrow erythroblasts, which transmits signals important for both proliferation and differentiation along the erythroid lineage. EPOR is a type 1 single-transmembrane cytokine receptor, and belongs to the homodimerizing subclass which functions as ligand-induced or ligand-stabilized homodimers. EPOR pre-exists as dimers which upon binding of a 34 kDa ligand erythropoietin (Epo), changes its homodimerized state. These conformational changes result in the autophosphorylation of Jak2 kinases that are pre-associated with the receptor. Erythropoietin is necessary to maintain endothelial cells and to promote tumor angiogenesis, hence the dysregulation of EpoR may affect the growth of certain tumors. EpoR signaling prevents neuronal death and ischemic injury.
This report aims to provide a comprehensive presentation of the global market for Erythropoietin Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erythropoietin Biosimilar. This report contains market size and forecasts of Erythropoietin Biosimilar in global, including the following market information:
Global Erythropoietin Biosimilar Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Erythropoietin Biosimilar Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Erythropoietin Biosimilar companies in 2023 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Erythropoietin Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erythropoietin Biosimilar Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Erythropoietin Biosimilar Market Segment Percentages, by Type, 2023 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Erythropoietin Biosimilar Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Erythropoietin Biosimilar Market Segment Percentages, by Application, 2023 (%)
Hematology
Kidney Disorder
Cancer
Others
Global Erythropoietin Biosimilar Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Erythropoietin Biosimilar Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erythropoietin Biosimilar revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Erythropoietin Biosimilar revenues share in global market, 2023 (%)
Key companies Erythropoietin Biosimilar sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Erythropoietin Biosimilar sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
VHB Life Sciences
Chengdu Di'Ao Pharmaceutical Group
Chalver Laboratorios
Fresenius Kabi
Neiss Labs
Micro Labs
Zuventus Healthcare
RPG Life Sciences
Unilab
Incepta Pharmaceuticals
Genius Biotherapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Erythropoietin Biosimilar, market overview.
Chapter 2: Global Erythropoietin Biosimilar market size in revenue and volume.
Chapter 3: Detailed analysis of Erythropoietin Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Erythropoietin Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Erythropoietin Biosimilar capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Erythropoietin Biosimilar Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Erythropoietin Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Erythropoietin Biosimilar Overall Market Size
2.1 Global Erythropoietin Biosimilar Market Size: 2023 VS 2030
2.2 Global Erythropoietin Biosimilar Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Erythropoietin Biosimilar Sales: 2019-2030
3 Company Landscape
3.1 Top Erythropoietin Biosimilar Players in Global Market
3.2 Top Global Erythropoietin Biosimilar Companies Ranked by Revenue
3.3 Global Erythropoietin Biosimilar Revenue by Companies
3.4 Global Erythropoietin Biosimilar Sales by Companies
3.5 Global Erythropoietin Biosimilar Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Erythropoietin Biosimilar Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Erythropoietin Biosimilar Product Type
3.8 Tier 1, Tier 2 and Tier 3 Erythropoietin Biosimilar Players in Global Market
3.8.1 List of Global Tier 1 Erythropoietin Biosimilar Companies
3.8.2 List of Global Tier 2 and Tier 3 Erythropoietin Biosimilar Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Erythropoietin Biosimilar Market Size Markets, 2023 & 2030
4.1.2 Hospital Pharmacy
4.1.3 Retail Pharmacy
4.1.4 Online Pharmacy
4.2 By Type - Global Erythropoietin Biosimilar Revenue & Forecasts
4.2.1 By Type - Global Erythropoietin Biosimilar Revenue, 2019-2024
4.2.2 By Type - Global Erythropoietin Biosimilar Revenue, 2025-2030
4.2.3 By Type - Global Erythropoietin Biosimilar Revenue Market Share, 2019-2030
4.3 By Type - Global Erythropoietin Biosimilar Sales & Forecasts
4.3.1 By Type - Global Erythropoietin Biosimilar Sales, 2019-2024
4.3.2 By Type - Global Erythropoietin Biosimilar Sales, 2025-2030
4.3.3 By Type - Global Erythropoietin Biosimilar Sales Market Share, 2019-2030
4.4 By Type - Global Erythropoietin Biosimilar Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Erythropoietin Biosimilar Market Size, 2023 & 2030
5.1.2 Hematology
5.1.3 Kidney Disorder
5.1.4 Cancer
5.1.5 Others
5.2 By Application - Global Erythropoietin Biosimilar Revenue & Forecasts
5.2.1 By Application - Global Erythropoietin Biosimilar Revenue, 2019-2024
5.2.2 By Application - Global Erythropoietin Biosimilar Revenue, 2025-2030
5.2.3 By Application - Global Erythropoietin Biosimilar Revenue Market Share, 2019-2030
5.3 By Application - Global Erythropoietin Biosimilar Sales & Forecasts
5.3.1 By Application - Global Erythropoietin Biosimilar Sales, 2019-2024
5.3.2 By Application - Global Erythropoietin Biosimilar Sales, 2025-2030
5.3.3 By Application - Global Erythropoietin Biosimilar Sales Market Share, 2019-2030
5.4 By Application - Global Erythropoietin Biosimilar Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Erythropoietin Biosimilar Market Size, 2023 & 2030
6.2 By Region - Global Erythropoietin Biosimilar Revenue & Forecasts
6.2.1 By Region - Global Erythropoietin Biosimilar Revenue, 2019-2024
6.2.2 By Region - Global Erythropoietin Biosimilar Revenue, 2025-2030
6.2.3 By Region - Global Erythropoietin Biosimilar Revenue Market Share, 2019-2030
6.3 By Region - Global Erythropoietin Biosimilar Sales & Forecasts
6.3.1 By Region - Global Erythropoietin Biosimilar Sales, 2019-2024
6.3.2 By Region - Global Erythropoietin Biosimilar Sales, 2025-2030
6.3.3 By Region - Global Erythropoietin Biosimilar Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Erythropoietin Biosimilar Revenue, 2019-2030
6.4.2 By Country - North America Erythropoietin Biosimilar Sales, 2019-2030
6.4.3 US Erythropoietin Biosimilar Market Size, 2019-2030
6.4.4 Canada Erythropoietin Biosimilar Market Size, 2019-2030
6.4.5 Mexico Erythropoietin Biosimilar Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Erythropoietin Biosimilar Revenue, 2019-2030
6.5.2 By Country - Europe Erythropoietin Biosimilar Sales, 2019-2030
6.5.3 Germany Erythropoietin Biosimilar Market Size, 2019-2030
6.5.4 France Erythropoietin Biosimilar Market Size, 2019-2030
6.5.5 U.K. Erythropoietin Biosimilar Market Size, 2019-2030
6.5.6 Italy Erythropoietin Biosimilar Market Size, 2019-2030
6.5.7 Russia Erythropoietin Biosimilar Market Size, 2019-2030
6.5.8 Nordic Countries Erythropoietin Biosimilar Market Size, 2019-2030
6.5.9 Benelux Erythropoietin Biosimilar Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Erythropoietin Biosimilar Revenue, 2019-2030
6.6.2 By Region - Asia Erythropoietin Biosimilar Sales, 2019-2030
6.6.3 China Erythropoietin Biosimilar Market Size, 2019-2030
6.6.4 Japan Erythropoietin Biosimilar Market Size, 2019-2030
6.6.5 South Korea Erythropoietin Biosimilar Market Size, 2019-2030
6.6.6 Southeast Asia Erythropoietin Biosimilar Market Size, 2019-2030
6.6.7 India Erythropoietin Biosimilar Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Erythropoietin Biosimilar Revenue, 2019-2030
6.7.2 By Country - South America Erythropoietin Biosimilar Sales, 2019-2030
6.7.3 Brazil Erythropoietin Biosimilar Market Size, 2019-2030
6.7.4 Argentina Erythropoietin Biosimilar Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Erythropoietin Biosimilar Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Erythropoietin Biosimilar Sales, 2019-2030
6.8.3 Turkey Erythropoietin Biosimilar Market Size, 2019-2030
6.8.4 Israel Erythropoietin Biosimilar Market Size, 2019-2030
6.8.5 Saudi Arabia Erythropoietin Biosimilar Market Size, 2019-2030
6.8.6 UAE Erythropoietin Biosimilar Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Erythropoietin Biosimilar Major Product Offerings
7.1.4 Pfizer Erythropoietin Biosimilar Sales and Revenue in Global (2019-2024)
7.1.5 Pfizer Key News & Latest Developments
7.2 VHB Life Sciences
7.2.1 VHB Life Sciences Company Summary
7.2.2 VHB Life Sciences Business Overview
7.2.3 VHB Life Sciences Erythropoietin Biosimilar Major Product Offerings
7.2.4 VHB Life Sciences Erythropoietin Biosimilar Sales and Revenue in Global (2019-2024)
7.2.5 VHB Life Sciences Key News & Latest Developments
7.3 Chengdu Di'Ao Pharmaceutical Group
7.3.1 Chengdu Di'Ao Pharmaceutical Group Company Summary
7.3.2 Chengdu Di'Ao Pharmaceutical Group Business Overview
7.3.3 Chengdu Di'Ao Pharmaceutical Group Erythropoietin Biosimilar Major Product Offerings
7.3.4 Chengdu Di'Ao Pharmaceutical Group Erythropoietin Biosimilar Sales and Revenue in Global (2019-2024)
7.3.5 Chengdu Di'Ao Pharmaceutical Group Key News & Latest Developments
7.4 Chalver Laboratorios
7.4.1 Chalver Laboratorios Company Summary
7.4.2 Chalver Laboratorios Business Overview
7.4.3 Chalver Laboratorios Erythropoietin Biosimilar Major Product Offerings
7.4.4 Chalver Laboratorios Erythropoietin Biosimilar Sales and Revenue in Global (2019-2024)
7.4.5 Chalver Laboratorios Key News & Latest Developments
7.5 Fresenius Kabi
7.5.1 Fresenius Kabi Company Summary
7.5.2 Fresenius Kabi Business Overview
7.5.3 Fresenius Kabi Erythropoietin Biosimilar Major Product Offerings
7.5.4 Fresenius Kabi Erythropoietin Biosimilar Sales and Revenue in Global (2019-2024)
7.5.5 Fresenius Kabi Key News & Latest Developments
7.6 Neiss Labs
7.6.1 Neiss Labs Company Summary
7.6.2 Neiss Labs Business Overview
7.6.3 Neiss Labs Erythropoietin Biosimilar Major Product Offerings
7.6.4 Neiss Labs Erythropoietin Biosimilar Sales and Revenue in Global (2019-2024)
7.6.5 Neiss Labs Key News & Latest Developments
7.7 Micro Labs
7.7.1 Micro Labs Company Summary
7.7.2 Micro Labs Business Overview
7.7.3 Micro Labs Erythropoietin Biosimilar Major Product Offerings
7.7.4 Micro Labs Erythropoietin Biosimilar Sales and Revenue in Global (2019-2024)
7.7.5 Micro Labs Key News & Latest Developments
7.8 Zuventus Healthcare
7.8.1 Zuventus Healthcare Company Summary
7.8.2 Zuventus Healthcare Business Overview
7.8.3 Zuventus Healthcare Erythropoietin Biosimilar Major Product Offerings
7.8.4 Zuventus Healthcare Erythropoietin Biosimilar Sales and Revenue in Global (2019-2024)
7.8.5 Zuventus Healthcare Key News & Latest Developments
7.9 RPG Life Sciences
7.9.1 RPG Life Sciences Company Summary
7.9.2 RPG Life Sciences Business Overview
7.9.3 RPG Life Sciences Erythropoietin Biosimilar Major Product Offerings
7.9.4 RPG Life Sciences Erythropoietin Biosimilar Sales and Revenue in Global (2019-2024)
7.9.5 RPG Life Sciences Key News & Latest Developments
7.10 Unilab
7.10.1 Unilab Company Summary
7.10.2 Unilab Business Overview
7.10.3 Unilab Erythropoietin Biosimilar Major Product Offerings
7.10.4 Unilab Erythropoietin Biosimilar Sales and Revenue in Global (2019-2024)
7.10.5 Unilab Key News & Latest Developments
7.11 Incepta Pharmaceuticals
7.11.1 Incepta Pharmaceuticals Company Summary
7.11.2 Incepta Pharmaceuticals Erythropoietin Biosimilar Business Overview
7.11.3 Incepta Pharmaceuticals Erythropoietin Biosimilar Major Product Offerings
7.11.4 Incepta Pharmaceuticals Erythropoietin Biosimilar Sales and Revenue in Global (2019-2024)
7.11.5 Incepta Pharmaceuticals Key News & Latest Developments
7.12 Genius Biotherapeutics
7.12.1 Genius Biotherapeutics Company Summary
7.12.2 Genius Biotherapeutics Erythropoietin Biosimilar Business Overview
7.12.3 Genius Biotherapeutics Erythropoietin Biosimilar Major Product Offerings
7.12.4 Genius Biotherapeutics Erythropoietin Biosimilar Sales and Revenue in Global (2019-2024)
7.12.5 Genius Biotherapeutics Key News & Latest Developments
8 Global Erythropoietin Biosimilar Production Capacity, Analysis
8.1 Global Erythropoietin Biosimilar Production Capacity, 2019-2030
8.2 Erythropoietin Biosimilar Production Capacity of Key Manufacturers in Global Market
8.3 Global Erythropoietin Biosimilar Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Erythropoietin Biosimilar Supply Chain Analysis
10.1 Erythropoietin Biosimilar Industry Value Chain
10.2 Erythropoietin Biosimilar Upstream Market
10.3 Erythropoietin Biosimilar Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Erythropoietin Biosimilar Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Erythropoietin Biosimilar in Global Market
Table 2. Top Erythropoietin Biosimilar Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Erythropoietin Biosimilar Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Erythropoietin Biosimilar Revenue Share by Companies, 2019-2024
Table 5. Global Erythropoietin Biosimilar Sales by Companies, (K Units), 2019-2024
Table 6. Global Erythropoietin Biosimilar Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Erythropoietin Biosimilar Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Erythropoietin Biosimilar Product Type
Table 9. List of Global Tier 1 Erythropoietin Biosimilar Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Erythropoietin Biosimilar Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Erythropoietin Biosimilar Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Erythropoietin Biosimilar Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Erythropoietin Biosimilar Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Erythropoietin Biosimilar Sales (K Units), 2019-2024
Table 15. By Type - Global Erythropoietin Biosimilar Sales (K Units), 2025-2030
Table 16. By Application ? Global Erythropoietin Biosimilar Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Erythropoietin Biosimilar Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Erythropoietin Biosimilar Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Erythropoietin Biosimilar Sales (K Units), 2019-2024
Table 20. By Application - Global Erythropoietin Biosimilar Sales (K Units), 2025-2030
Table 21. By Region ? Global Erythropoietin Biosimilar Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Erythropoietin Biosimilar Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Erythropoietin Biosimilar Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Erythropoietin Biosimilar Sales (K Units), 2019-2024
Table 25. By Region - Global Erythropoietin Biosimilar Sales (K Units), 2025-2030
Table 26. By Country - North America Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Erythropoietin Biosimilar Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Erythropoietin Biosimilar Sales, (K Units), 2019-2024
Table 29. By Country - North America Erythropoietin Biosimilar Sales, (K Units), 2025-2030
Table 30. By Country - Europe Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Erythropoietin Biosimilar Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Erythropoietin Biosimilar Sales, (K Units), 2019-2024
Table 33. By Country - Europe Erythropoietin Biosimilar Sales, (K Units), 2025-2030
Table 34. By Region - Asia Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Erythropoietin Biosimilar Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Erythropoietin Biosimilar Sales, (K Units), 2019-2024
Table 37. By Region - Asia Erythropoietin Biosimilar Sales, (K Units), 2025-2030
Table 38. By Country - South America Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Erythropoietin Biosimilar Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Erythropoietin Biosimilar Sales, (K Units), 2019-2024
Table 41. By Country - South America Erythropoietin Biosimilar Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Erythropoietin Biosimilar Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Erythropoietin Biosimilar Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Erythropoietin Biosimilar Sales, (K Units), 2025-2030
Table 46. Pfizer Company Summary
Table 47. Pfizer Erythropoietin Biosimilar Product Offerings
Table 48. Pfizer Erythropoietin Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Pfizer Key News & Latest Developments
Table 50. VHB Life Sciences Company Summary
Table 51. VHB Life Sciences Erythropoietin Biosimilar Product Offerings
Table 52. VHB Life Sciences Erythropoietin Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. VHB Life Sciences Key News & Latest Developments
Table 54. Chengdu Di'Ao Pharmaceutical Group Company Summary
Table 55. Chengdu Di'Ao Pharmaceutical Group Erythropoietin Biosimilar Product Offerings
Table 56. Chengdu Di'Ao Pharmaceutical Group Erythropoietin Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Chengdu Di'Ao Pharmaceutical Group Key News & Latest Developments
Table 58. Chalver Laboratorios Company Summary
Table 59. Chalver Laboratorios Erythropoietin Biosimilar Product Offerings
Table 60. Chalver Laboratorios Erythropoietin Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Chalver Laboratorios Key News & Latest Developments
Table 62. Fresenius Kabi Company Summary
Table 63. Fresenius Kabi Erythropoietin Biosimilar Product Offerings
Table 64. Fresenius Kabi Erythropoietin Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Fresenius Kabi Key News & Latest Developments
Table 66. Neiss Labs Company Summary
Table 67. Neiss Labs Erythropoietin Biosimilar Product Offerings
Table 68. Neiss Labs Erythropoietin Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Neiss Labs Key News & Latest Developments
Table 70. Micro Labs Company Summary
Table 71. Micro Labs Erythropoietin Biosimilar Product Offerings
Table 72. Micro Labs Erythropoietin Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Micro Labs Key News & Latest Developments
Table 74. Zuventus Healthcare Company Summary
Table 75. Zuventus Healthcare Erythropoietin Biosimilar Product Offerings
Table 76. Zuventus Healthcare Erythropoietin Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Zuventus Healthcare Key News & Latest Developments
Table 78. RPG Life Sciences Company Summary
Table 79. RPG Life Sciences Erythropoietin Biosimilar Product Offerings
Table 80. RPG Life Sciences Erythropoietin Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. RPG Life Sciences Key News & Latest Developments
Table 82. Unilab Company Summary
Table 83. Unilab Erythropoietin Biosimilar Product Offerings
Table 84. Unilab Erythropoietin Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Unilab Key News & Latest Developments
Table 86. Incepta Pharmaceuticals Company Summary
Table 87. Incepta Pharmaceuticals Erythropoietin Biosimilar Product Offerings
Table 88. Incepta Pharmaceuticals Erythropoietin Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Incepta Pharmaceuticals Key News & Latest Developments
Table 90. Genius Biotherapeutics Company Summary
Table 91. Genius Biotherapeutics Erythropoietin Biosimilar Product Offerings
Table 92. Genius Biotherapeutics Erythropoietin Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Genius Biotherapeutics Key News & Latest Developments
Table 94. Erythropoietin Biosimilar Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 95. Global Erythropoietin Biosimilar Capacity Market Share of Key Manufacturers, 2022-2024
Table 96. Global Erythropoietin Biosimilar Production by Region, 2019-2024 (K Units)
Table 97. Global Erythropoietin Biosimilar Production by Region, 2025-2030 (K Units)
Table 98. Erythropoietin Biosimilar Market Opportunities & Trends in Global Market
Table 99. Erythropoietin Biosimilar Market Drivers in Global Market
Table 100. Erythropoietin Biosimilar Market Restraints in Global Market
Table 101. Erythropoietin Biosimilar Raw Materials
Table 102. Erythropoietin Biosimilar Raw Materials Suppliers in Global Market
Table 103. Typical Erythropoietin Biosimilar Downstream
Table 104. Erythropoietin Biosimilar Downstream Clients in Global Market
Table 105. Erythropoietin Biosimilar Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Erythropoietin Biosimilar Segment by Type in 2023
Figure 2. Erythropoietin Biosimilar Segment by Application in 2023
Figure 3. Global Erythropoietin Biosimilar Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Erythropoietin Biosimilar Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Erythropoietin Biosimilar Revenue, 2019-2030 (US$, Mn)
Figure 7. Erythropoietin Biosimilar Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Erythropoietin Biosimilar Revenue in 2023
Figure 9. By Type - Global Erythropoietin Biosimilar Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Erythropoietin Biosimilar Revenue Market Share, 2019-2030
Figure 11. By Type - Global Erythropoietin Biosimilar Sales Market Share, 2019-2030
Figure 12. By Type - Global Erythropoietin Biosimilar Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Erythropoietin Biosimilar Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Erythropoietin Biosimilar Revenue Market Share, 2019-2030
Figure 15. By Application - Global Erythropoietin Biosimilar Sales Market Share, 2019-2030
Figure 16. By Application - Global Erythropoietin Biosimilar Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Erythropoietin Biosimilar Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Erythropoietin Biosimilar Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Erythropoietin Biosimilar Revenue Market Share, 2019-2030
Figure 20. By Region - Global Erythropoietin Biosimilar Sales Market Share, 2019-2030
Figure 21. By Country - North America Erythropoietin Biosimilar Revenue Market Share, 2019-2030
Figure 22. By Country - North America Erythropoietin Biosimilar Sales Market Share, 2019-2030
Figure 23. US Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Erythropoietin Biosimilar Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Erythropoietin Biosimilar Sales Market Share, 2019-2030
Figure 28. Germany Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 29. France Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Erythropoietin Biosimilar Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Erythropoietin Biosimilar Sales Market Share, 2019-2030
Figure 37. China Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 41. India Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Erythropoietin Biosimilar Revenue Market Share, 2019-2030
Figure 43. By Country - South America Erythropoietin Biosimilar Sales Market Share, 2019-2030
Figure 44. Brazil Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Erythropoietin Biosimilar Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Erythropoietin Biosimilar Sales Market Share, 2019-2030
Figure 48. Turkey Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Erythropoietin Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 52. Global Erythropoietin Biosimilar Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Erythropoietin Biosimilar by Region, 2023 VS 2030
Figure 54. Erythropoietin Biosimilar Industry Value Chain
Figure 55. Marketing Channels
